Raymond James Financial Inc. Buys New Position in iShares U.S. Pharmaceuticals ETF (NYSEARCA:IHE)

Raymond James Financial Inc. bought a new stake in iShares U.S. Pharmaceuticals ETF (NYSEARCA:IHE) in the 4th quarter, HoldingsChannel.com reports. The institutional investor bought 68,051 shares of the company’s stock, valued at approximately $4,472,000.

Other institutional investors and hedge funds also recently bought and sold shares of the company. Wealth Enhancement Advisory Services LLC boosted its stake in shares of iShares U.S. Pharmaceuticals ETF by 11.0% in the fourth quarter. Wealth Enhancement Advisory Services LLC now owns 3,589 shares of the company’s stock valued at $253,000 after purchasing an additional 356 shares during the period. Truist Financial Corp lifted its holdings in iShares U.S. Pharmaceuticals ETF by 46.6% during the 4th quarter. Truist Financial Corp now owns 11,246 shares of the company’s stock worth $739,000 after buying an additional 3,576 shares in the last quarter. Jane Street Group LLC boosted its position in iShares U.S. Pharmaceuticals ETF by 5.5% in the 3rd quarter. Jane Street Group LLC now owns 11,846 shares of the company’s stock valued at $836,000 after buying an additional 616 shares during the period. FMR LLC grew its stake in shares of iShares U.S. Pharmaceuticals ETF by 10.9% in the third quarter. FMR LLC now owns 13,581 shares of the company’s stock worth $959,000 after acquiring an additional 1,338 shares in the last quarter. Finally, Thrivent Financial for Lutherans increased its position in shares of iShares U.S. Pharmaceuticals ETF by 23.6% during the third quarter. Thrivent Financial for Lutherans now owns 32,509 shares of the company’s stock worth $2,295,000 after acquiring an additional 6,214 shares during the period.

iShares U.S. Pharmaceuticals ETF Trading Down 1.9 %

Shares of NYSEARCA IHE opened at $69.58 on Wednesday. The stock has a market cap of $612.30 million, a P/E ratio of 25.04 and a beta of 0.63. The business’s fifty day simple moving average is $70.03 and its 200-day simple moving average is $69.29. iShares U.S. Pharmaceuticals ETF has a 12-month low of $62.68 and a 12-month high of $73.28.

iShares U.S. Pharmaceuticals ETF Profile

iShares U.S. Pharmaceuticals ETF, formerly iShares Dow Jones U.S. Pharmaceuticals Index Fund (the Fund), is an exchange traded fund. The Fund seeks investment results that correspond generally to the price and yield performance of the Dow Jones U.S. Select Pharmaceuticals Index (the Index). The Index measures the performance of the pharmaceuticals sector of the United States equity market, and includes pharmaceutical companies such as manufacturers of prescription or over-the-counter drugs or vaccines, but excludes producers of vitamins.